In line with this notion, we found that expression of the generic proliferation marker MKI67, WNT- and MYC-target genes, and the KEGG pathway ‘cell-cycle’ are expressed at significantly lower levels in CMS4 than in any of the other subtypes in primary colon cancer (Figure 4A). This evidence concerns the gene MKI67 and colonic neoplasm.